Logo image
Back
Device-Associated Menstrual Toxic Shock Syndrome
Journal article   Peer reviewed

Device-Associated Menstrual Toxic Shock Syndrome

Patrick M Schlievert and Catherine C Davis
Clinical microbiology reviews, Vol.33(3), e00032-19
06/17/2020
DOI: 10.1128/CMR.00032-19
PMID: 32461307
url
https://www.ncbi.nlm.nih.gov/pmc/articles/7254860View
Open Access

Abstract

In the 1980s, menstrual toxic shock syndrome (mTSS) became a household topic, particularly among mothers and their daughters. The research performed at the time, and for the first time, exposed the American public as well as the biomedical community, in a major way, to understanding disease progression and investigation. Those studies led to the identification of the cause, and the pyrogenic toxin superantigen TSS toxin 1 (TSST-1), and many of the risk factors, for example, tampon use. Those studies in turn led to TSS warning labels on the outside and inside of tampon boxes and, as important, uniform standards worldwide of tampon absorbency labeling. This review addresses our understanding of the development and conclusions related to mTSS and risk factors. We leave the final message that even though mTSS is not commonly in the news today, cases continue to occur. Additionally, strains cycle in human populations in roughly 10-year intervals, possibly dependent on immune status. TSST-1-producing bacteria appear to be reemerging, suggesting that physician awareness of this emergence and mTSS history should be heightened.
 Menstruation Superantigens - toxicity Enterotoxins - toxicity Humans Risk Factors Shock, Septic - epidemiology Bacterial Toxins - toxicity Female Menstrual Hygiene Products - adverse effects Staphylococcal Infections - microbiology Staphylococcus aureus - pathogenicity Shock, Septic - microbiology

Details

Metrics

34 Record Views
52 Times Cited - Web of Science
Logo image